{"id":9678,"date":"2025-12-28T22:29:42","date_gmt":"2025-12-28T13:29:42","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4974\/"},"modified":"2026-08-09T13:18:45","modified_gmt":"2026-08-09T04:18:45","slug":"company-4974","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4974\/","title":{"rendered":"TAKARA BIO INC"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4974","DATE":"2026-01-09","longName":"Takara Bio Inc.","company_name_ja":"\u30bf\u30ab\u30e9\u30d0\u30a4\u30aa(\u682a)","fullTimeEmployees":1779,"address":"","phone":"","website":"https:\/\/www.takara-bio.com","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":820,"financialCurrency":"","marketCap":98740,"fiftyTwoWeekLow":711,"fiftyTwoWeekHigh":1058,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":45039000000,"OperatingIncome":2266000000,"operatingMargins":5.0300000000000002,"NetIncome":1041000000,"profitMargins":2.3100000000000001,"ebitda":0,"trailingPE":0,"forwardPE":23.111612000000001,"priceToBook":0.9644722,"returnOnEquity":0.90000000000000002,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":1900,"numberOfAnalystOpinions":1,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:39:58.394058\", \"ticker\": \"4974\", \"ticker_full\": \"4974.T\", \"company_name\": \"TAKARA BIO INC\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"0\", \"strong_buy\": 0, \"buy\": 1, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 1, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 1144.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-07\", \"eps_estimate\": null, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": []}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 87.27, \"institution_pct\": 4.63, \"major_holders\": [{\"label\": \"\", \"value\": 87.27}, {\"label\": \"\", \"value\": 4.63}, {\"label\": \"\", \"value\": 36.34}, {\"label\": \"\", \"value\": 45.0}], \"institutional_holders\": [{\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 662320, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.55, \"pct_change\": 0.0, \"value\": 757694080}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 460123, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.38, \"pct_change\": 10.49, \"value\": 526380712}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 221899, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.18, \"pct_change\": 32.0, \"value\": 253852456}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap \", \"shares\": 171600, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.14, \"pct_change\": 0.0, \"value\": 196310400}, {\"holder\": \"Dimensional ETF Trust-Dimensional International Small Cap ETF\", \"shares\": 160900, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.13, \"pct_change\": 12.75, \"value\": 184069600}, {\"holder\": \"DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.\", \"shares\": 109200, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.09, \"pct_change\": -34.96, \"value\": 124924800}, {\"holder\": \"SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF\", \"shares\": 102010, \"date_reported\": \"2026-02-28\", \"pct_held\": 0.08, \"pct_change\": -1.14, \"value\": 116699440}, {\"holder\": \"Dimensional ETF Trust-Dimensional International Core Equity 2 ETF\", \"shares\": 86494, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.07, \"pct_change\": 14.27, \"value\": 98949136}, {\"holder\": \"VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Pacific Stock Index Fd.\", \"shares\": 53286, \"date_reported\": \"2026-01-31\", \"pct_held\": 0.04, \"pct_change\": 0.0, \"value\": 60959184}, {\"holder\": \"College Retirement Equities Fd.-College Retirement Equities Fd. - Tota\", \"shares\": 39833, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.03, \"pct_change\": 0.0, \"value\": 45568952}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":2.0699999999999998,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Takara Bio Inc., together with its subsidiaries, engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including reagents needed for genetic and cellular research, PCR instruments, cellular analysis devices, and in vitro diagnostics for COVID-19 testing. It also provides contract services related to regenerative medicine products and contract services related to gene analysis and testing. In addition, the company is involved in commercialization of its proprietary platform technology for biologics development; development, manufacture, and sale of manufacture ancillary materials, such as RetroNectin that is used in the manufacture of gene therapy product; application for marketing authorization of NY-ESO-1 siTCR gene therapy product; and development of JAK\/STAT technology suitable for CAR gene therapy and applied development of CereAAV, a brain-tropic adeno-associated virus vector. It provides its products and services through sales agents or directly to its customers. The company was incorporated in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":17,"get_dividend_history_year2":17,"get_dividend_history_year3":42,"get_dividend_history_year4":33,"get_dividend_history_year5":9,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-09T03:04:07.074601\", \"ticker\": \"4974\", \"ticker_full\": \"4974.T\", \"company_name\": \"TAKARA BIO INC\", \"company_info\": {\"name_en\": \"TAKARA BIO INC\", \"long_name\": \"Takara Bio Inc.\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.takara-bio.com\", \"employees\": null, \"country\": \"Japan\", \"city\": \"Kusatsu\", \"address\": \"7-4-38 Nojihigashi\", \"description\": \"Takara Bio Inc., together with its subsidiaries, engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including reagents needed for genetic and cellular research, PCR instruments, cellular analysis devices, and in vitro diagnostics for COVID-19 testing. It also provides contract services related to regenerative medicine products and contract services related to gene analysis and testing. In addition, the company is involved in commercialization of its proprietary platform technology for biologics development; development, manufacture, and sale of manufacture ancillary materials, such as RetroNectin that is used in the manufacture of gene therapy product; application for marketing authorization of NY-ESO-1 siTCR gene therapy product; and development of JAK\/STAT technology suitable for CAR gene therapy and applied development of CereAAV, a brain-tropic adeno-associated virus vector. It provides its products and services through sales agents or directly to its customers. The company was incorporated in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}, \"ma_25\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}, \"ma_75\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}, \"ma_200\": {\"ma_value\": 0, \"deviation\": 0, \"trend\": \"neutral\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 45039000000.0, \"revenue_fmt\": \"\u00a5450\u5104\", \"gross_profit\": 26067000000.0, \"gross_profit_fmt\": \"\u00a5261\u5104\", \"operating_income\": 2266000000.0, \"operating_income_fmt\": \"\u00a523\u5104\", \"ebit\": 2017000000.0, \"ebit_fmt\": \"\u00a520\u5104\", \"net_income\": 1041000000.0, \"net_income_fmt\": \"\u00a510\u5104\", \"eps\": 0, \"operating_margin\": 5.03, \"total_assets\": 125334000000.0, \"total_assets_fmt\": \"\u00a51253\u5104\", \"total_equity\": 115498000000.0, \"total_equity_fmt\": \"\u00a51155\u5104\", \"total_debt\": 1101000000.0, \"total_debt_fmt\": \"\u00a511\u5104\", \"total_cash\": 29549000000.0, \"total_cash_fmt\": \"\u00a5295\u5104\", \"equity_ratio\": 92.15, \"de_ratio\": 0.01, \"current_ratio\": 8.09, \"operating_cf\": 5844000000.0, \"operating_cf_fmt\": \"\u00a558\u5104\", \"investing_cf\": -10912000000.0, \"investing_cf_fmt\": \"-\u00a5109\u5104\", \"financing_cf\": -2256000000.0, \"financing_cf_fmt\": \"-\u00a523\u5104\", \"free_cf\": -4434000000.0, \"free_cf_fmt\": \"-\u00a544\u5104\", \"net_margin\": 2.31, \"roe\": 0.9, \"roa\": 0.83}, {\"year\": 2024, \"revenue\": 43505000000.0, \"revenue_fmt\": \"\u00a5435\u5104\", \"gross_profit\": 26908000000.0, \"gross_profit_fmt\": \"\u00a5269\u5104\", \"operating_income\": 3004000000.0, \"operating_income_fmt\": \"\u00a530\u5104\", \"ebit\": 2876000000.0, \"ebit_fmt\": \"\u00a529\u5104\", \"net_income\": 1480000000.0, \"net_income_fmt\": \"\u00a515\u5104\", \"eps\": 0, \"operating_margin\": 6.9, \"total_assets\": 121252000000.0, \"total_assets_fmt\": \"\u00a51213\u5104\", \"total_equity\": 111503000000.0, \"total_equity_fmt\": \"\u00a51115\u5104\", \"total_debt\": 968000000.0, \"total_debt_fmt\": \"\u00a510\u5104\", \"total_cash\": 35416000000.0, \"total_cash_fmt\": \"\u00a5354\u5104\", \"equity_ratio\": 91.96, \"de_ratio\": 0.01, \"current_ratio\": 8.76, \"operating_cf\": 1711000000.0, \"operating_cf_fmt\": \"\u00a517\u5104\", \"investing_cf\": -13043000000.0, \"investing_cf_fmt\": \"-\u00a5130\u5104\", \"financing_cf\": -5233000000.0, \"financing_cf_fmt\": \"-\u00a552\u5104\", \"free_cf\": -11161000000.0, \"free_cf_fmt\": \"-\u00a5112\u5104\", \"net_margin\": 3.4, \"roe\": 1.33, \"roa\": 1.22}, {\"year\": 2023, \"revenue\": 78142000000.0, \"revenue_fmt\": \"\u00a5781\u5104\", \"gross_profit\": 44765000000.0, \"gross_profit_fmt\": \"\u00a5448\u5104\", \"operating_income\": 20546000000.0, \"operating_income_fmt\": \"\u00a5205\u5104\", \"ebit\": 21248000000.0, \"ebit_fmt\": \"\u00a5212\u5104\", \"net_income\": 16012000000.0, \"net_income_fmt\": \"\u00a5160\u5104\", \"eps\": 0, \"operating_margin\": 26.29, \"total_assets\": 129202000000.0, \"total_assets_fmt\": \"\u00a51292\u5104\", \"total_equity\": 112217000000.0, \"total_equity_fmt\": \"\u00a51122\u5104\", \"total_debt\": 972000000.0, \"total_debt_fmt\": \"\u00a510\u5104\", \"total_cash\": 51847000000.0, \"total_cash_fmt\": \"\u00a5518\u5104\", \"equity_ratio\": 86.85, \"de_ratio\": 0.01, \"current_ratio\": 5.4, \"operating_cf\": 36897000000.0, \"operating_cf_fmt\": \"\u00a5369\u5104\", \"investing_cf\": -6693000000.0, \"investing_cf_fmt\": \"-\u00a567\u5104\", \"financing_cf\": -4119000000.0, \"financing_cf_fmt\": \"-\u00a541\u5104\", \"free_cf\": 31015000000.0, \"free_cf_fmt\": \"\u00a5310\u5104\", \"net_margin\": 20.49, \"roe\": 14.27, \"roa\": 12.39}, {\"year\": 2022, \"revenue\": 67699000000.0, \"revenue_fmt\": \"\u00a5677\u5104\", \"gross_profit\": 49211000000.0, \"gross_profit_fmt\": \"\u00a5492\u5104\", \"operating_income\": 28904000000.0, \"operating_income_fmt\": \"\u00a5289\u5104\", \"ebit\": 27555000000.0, \"ebit_fmt\": \"\u00a5276\u5104\", \"net_income\": 19849000000.0, \"net_income_fmt\": \"\u00a5198\u5104\", \"eps\": 0, \"operating_margin\": 42.69, \"total_assets\": 115712000000.0, \"total_assets_fmt\": \"\u00a51157\u5104\", \"total_equity\": 95871000000.0, \"total_equity_fmt\": \"\u00a5959\u5104\", \"total_debt\": 1047000000.0, \"total_debt_fmt\": \"\u00a510\u5104\", \"total_cash\": 23633000000.0, \"total_cash_fmt\": \"\u00a5236\u5104\", \"equity_ratio\": 82.85, \"de_ratio\": 0.01, \"current_ratio\": 3.92, \"operating_cf\": 6985000000.0, \"operating_cf_fmt\": \"\u00a570\u5104\", \"investing_cf\": -7071000000.0, \"investing_cf_fmt\": \"-\u00a571\u5104\", \"financing_cf\": -2070000000.0, \"financing_cf_fmt\": \"-\u00a521\u5104\", \"free_cf\": -5554000000.0, \"free_cf_fmt\": \"-\u00a556\u5104\", \"net_margin\": 29.32, \"roe\": 20.7, \"roa\": 17.15}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":811.60000000000002,"ma_5_deviation":1.03,"ma_5_trend":"up","ma_25_value":790.24000000000001,"ma_25_deviation":3.77,"ma_25_trend":"up","ma_75_value":872.42999999999995,"ma_75_deviation":-6.0099999999999998,"ma_75_trend":"down","ma_200_value":847.89999999999998,"ma_200_deviation":-3.29,"ma_200_trend":"down","previousClose":822,"open":826,"dayHigh":833,"dayLow":817,"volume":200400,"averageVolume":337620,"revenueGrowth":0},"sector":[],"class_list":["post-9678","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TAKARA BIO INC - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4974\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4974\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4974\/\",\"name\":\"TAKARA BIO INC - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-28T13:29:42+00:00\",\"dateModified\":\"2026-08-09T04:18:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4974\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4974\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4974\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TAKARA BIO INC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TAKARA BIO INC - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4974\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4974\/","url":"https:\/\/japanir.jp\/en\/company\/company-4974\/","name":"TAKARA BIO INC - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-28T13:29:42+00:00","dateModified":"2026-08-09T04:18:45+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4974\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4974\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4974\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"TAKARA BIO INC"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/9678","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=9678"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=9678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}